logo
15:58 Jan 28

Zydus Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
896.90
+3.55 (+0.40%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Zydus Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
896.90
+3.55 (+0.40%)
15:58 Jan 28
Quality
image/svg+xml

66/100
High Financial Strength

Valuation
image/svg+xml

43/100
Mid Valuation

Technical

33/100
Technically Bearish

Strength

11

Weakness

1

Opportunity

0

Threats

0

18.89 %

ROE %

12.16 %

ROA %

48.92

EPS

238.10

BVPS

19.47 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
14403.5 15265.2 17237.4 19547.4 23241.5
Operating Expenses +
11016.4 11924.5 13377.5 14163.1 16183
Raw Material
4958.3 5907.5 6072 6478.4 6522.9
Increase Decrease in Cost
-156.2 -362.3 238.1 -250.2 -184.9
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
2295.1 2434.1 2765.6 3137.6 3680.6
Miscellaneous Expenses
6497.8 7674.4 8200.6 8593.1 10464.4
Operating Profit
3387.1 3340.7 3859.9 5384.3 7058.5
Other Income
45.6 224.7 186.6 284.1 269.5
Depreciation
669.6 713 722.7 764.1 915.8
Interest
158.8 127 129.9 81.2 165.9
Profit before tax and exceptio..
2604.3 2725.4 3193.9 4823.1 6246.3
Exceptional Items
-205.1 112.7 -604.2 -14.2 -219.6
PBT
2399.2 2838.1 2589.7 4808.9 6026.7
Provision for Taxation
193.6 511.7 587.8 977.5 1411.9
Net Profit
2137.6 4572.1 1997.3 3854.4 4614.8
NET Profit after MI
2133.6 4487.3 1960.3 3859.5 4525.5
EPS
20.84 43.83 19.3 38.14 44.97
Operating Profit Margin (%)
23.52 21.88 22.39 27.54 30.37
Net Profit Margin (%)
14.81 29.4 11.37 19.74 19.47

Zydus Lifesciences Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 75.00 75.00 75.00 75.00 75.00 75.00
FII 7.10 7.30 7.10 7.30 7.50 7.50
Public 11.00 10.90 11.20 11.00 10.70 10.70
Others 6.90 6.80 6.70 6.70 6.80 6.80
Shareholder Shares Holding %
Research 360 logo
Download Our App On: